CD1D and acute myeloid leukemia: showed that ex vivo expanded human iNKT cells recognized and killed AML cells in a CD1d-TCR-dependent manner, and also helped restore anti-leukemic activity of T cells despite an immunosuppressive leukemic microenvironment (151).